Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bladder cancer
bladder cancer
Ferring, with manufacturing update, takes a step towards first gene therapy sales
BioPharma Dive
Wed, 06/14/23 - 10:07 am
Ferring Pharmaceuticals
FDA
bladder cancer
gene therapy
Adstiladrin
Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug
BioSpace
Thu, 06/8/23 - 10:13 am
Eli Lilly
Takeda
legal
Actos
bladder cancer
diabetes
racketeering
ASCO: Johnson & Johnson's Balversa tops chemotherapy in bladder cancer trial
Fierce Pharma
Mon, 06/5/23 - 10:02 pm
ASCO 2023
JNJ
Balversa
bladder cancer
AstraZeneca study points to new uses for targeted cancer drug Enhertu
BioPharma Dive
Mon, 06/5/23 - 11:32 am
ASCO 2023
AstraZeneca
Enhertu
uterine cancer
cervical cancer
ovarian cancer
bladder cancer
Immunitybio slumps as FDA declines to approve bladder cancer treatment
NASDAQ
Thu, 05/11/23 - 09:58 am
ImmunityBio
FDA
bladder cancer
anktiva
GSK's bellwether Zantac court date pushed to July
Endpoints
Sun, 02/26/23 - 10:11 pm
GSK
Zantac
legal
bladder cancer
A renewed push into early bladder cancer
EP Vantage
Thu, 02/2/23 - 10:24 am
Ferring Pharmaceuticals
Adstiladrin
FDA
gene therapy
bladder cancer
Ferring wins FDA approval for bladder cancer gene therapy
BioPharma Dive
Tue, 12/20/22 - 11:07 am
Ferring Pharmaceuticals
bladder cancer
gene therapy
FDA
Adstiladrin
UroGen reports data from Phase IIb trial of bladder cancer treatment
Clinical Trials Arena
Mon, 12/5/22 - 10:51 am
Urogen
clinical trials
UGN-102
bladder cancer
Roche Withdraws Tecentric for Bladder Cancer Indication
BioSpace
Tue, 11/29/22 - 11:06 am
Roche
Genentech
bladder cancer
metastatic bladder cancer
Tecentriq
A startup plans an IPO to give a shelved Lilly drug another shot
BioPharma Dive
Wed, 10/19/22 - 10:39 am
Acrivon Therapeutics
IPOs
Eli Lilly
prexasertib
ovarian cancer
endometrial cancer
bladder cancer
precision medicine
Modified bladder cancer treatment shows promise
Drugs.com
Tue, 08/23/22 - 10:29 pm
bladder cancer
vaccines
Texas Biomedical Research Institute
ImmunityBio’s Bladder Cancer Immunotherapy BLA gets FDA Nod
BioSpace
Mon, 08/1/22 - 10:29 am
ImmunityBio
FDA
N-803
bladder cancer
Seagen, Astellas claim positive results in study key to cancer drug's success
BioPharma Dive
Tue, 07/26/22 - 11:26 am
Seagen
Astellas
Padcev
Merck
Keytruda
bladder cancer
clinical trials
Sesen slams brakes on phase 3 bladder cancer program to save cash as it looks for off-ramp
Fierce Biotech
Mon, 07/18/22 - 07:15 pm
Sesen Bio
bladder cancer
clinical trials
Vicineum
ImmunityBio’s Patrick Soon-Shiong Discusses Quest to Orchestrate NK and T Cells
BioSpace
Thu, 06/16/22 - 10:21 am
ImmunityBio
Pantrick Soon-Shiong
bladder cancer
FDA
N-803
Bristol Myers scraps $2B Nektar partnership after trial failures
BioPharma Dive
Mon, 04/18/22 - 11:42 pm
Bristol Myers Squibb
Nektar Therapeutics
immunotherapy
Opdivo
kidney cancer
bladder cancer
BMS and Nektar Shutter Combination Cancer Development Program
BioSpace
Fri, 04/15/22 - 01:42 pm
Bristol Myers Squibb
Nektar Therapeutics
bladder cancer
renal cell carcinoma
bempegaldesleukin
Trial win sets up new use for Astellas, Seagen’s Padcev in bladder cancer
Pharmaforum
Mon, 02/14/22 - 11:44 pm
Astellas
Seagen
Padcev
bladder cancer
clinical trials
Merck's Keytruda survives FDA scrutiny in bladder cancer, but ends up with a smaller label
Fierce Pharma
Wed, 09/1/21 - 01:26 pm
Merck
Keytruda
FDA
bladder cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »